Logo
x

Search

Subscribe Now

Celltrion

Celltrion launches SteQeyma (Biosimilar, Stelara) in the US

Celltrion launches SteQeyma (Biosimilar, Stelara) in the US

  • March 13, 2025
Celltrion’s Omlyclo (Biosimilar, Xolair) Secures the US FDA’s Approval

Celltrion’s Omlyclo (Biosimilar, Xolair) Secures the US FDA’s Approval

  • March 10, 2025
Celltrion Reports the US FDA approval for Stoboclo & Osenvelt (Biosimilars, Prolia & Xgeva)

Celltrion Reports the US FDA approval for Stoboclo & Osenvelt (Biosimilars, Prolia & Xgeva)

  • March 5, 2025
Celltrion Secures the EC’s Approval for Avtozma (Biosimilar, RoActemra)

Celltrion Secures the EC’s Approval for Avtozma (Biosimilar, RoActemra)

  • February 24, 2025
Celltrion Secures the EC’s Approval for Eydenzelt (Biosimilar, Eylea), Stoboclo & Osenvelt (Biosimilars, Prolia & Xgeva)

Celltrion Secures the EC’s Approval for Eydenzelt (Biosimilar, Eylea), Stoboclo & Osenvelt (Biosimilars, Prolia & Xgeva)

  • February 19, 2025
Celltrion Secures the US FDA’s Approval for Avtozma IV/SC (Biosimilar, Actemra)

Celltrion Secures the US FDA’s Approval for Avtozma IV/SC (Biosimilar, Actemra)

  • February 12, 2025
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2025 PharmaShots - All Rights Reserved.